Back

Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DdNdC gene therapy: eight-year follow-up of phase 1 KAT301 study

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Basic science e-posters Gene Therapy, Cell Therapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Mr Aleksi Johannes Leikas

Kuopio University Hospital, Kuopio (Finland)

202 More presentations in this session

Presentation thumbnail
Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress
Doctor T. Yamamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes
Doctor C. Lo (Miaoli, TW)
Abstract Slides
Presentation thumbnail
Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense
Professor I. Andreadou (Athens, GR)
Abstract Slides
Presentation thumbnail
Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Melatonin receptor blockade slows ventricular conduction by IK1 downregulation
Doctor M. Gonotkov (Syktyvkar, RU)
Abstract Slides

Access the full session

Session thumbnail
Basic science e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of long-term safety of pro-angiogenic growth approaches in cardiovascular disease: A systematic review
28 August 2026
thumbnail
Congress Presentation
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
12 April 2024
thumbnail
Congress Presentation
Long-term effect of an ICD in nonischemic heart failure with reduced ejection fraction over 13 years An extended follow-up analysis of DANISH
1 September 2025
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources